Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.


Main focus: Many different therapeutic areas including oncology, cardiovascular, neurological diseases and others

Company stage: Commercial

Diseases: Undisclosed

Genome editing technology: CRISPR-Cas9

Funding stage: Public (NASDAQ:AZN)

Location: Cambridge, England



AstraZeneca is a public, clinical-stage big pharma company focused on a wide array of therapeutic areas. AstraZeneca has worked with CRISPR-based therapeutic models on several occasions. The company demonstrated the use of CRISPR to reverse a mutation causing enzyme deficiency in an α1-antitrypsin-deficient mouse model. The company is also working closely with several global laboratories to develop new CRISPR tools such as CRISPR GUARD, CRISPR VIVO and DISCover-seq.



Company: AstraZeneca
Jobs, banner ads, webinars, sponsored content...
Search CRISPR Medicine